We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...

Industry members have described a shift in the last 18 months in regulatory bodies’ interest in how AI is used in drug development. The FDA’s new draft guidance comes on the heels of a ...

That’s the environment where Venkatesh Kanneganti, a senior IEEE member, and a seasoned Quality Assurance and validation leader with over 12 years of experience across North America and Asia, has made ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, March 26). Regulatory Trends in Pharma Manufacturing: Key Changes to Watch in ...

Regulatory oversight may also be needed to identify and correct shortages of anti-infective drugs, the authors said. Related Articles on Medication Safety: Jury Awards $12M to Patient Who Suffered ...

CDSCO revises guidance for issuing No Objection Certificates (NOCs) for new drug formulations intended for export. The ...

Overdosing can lead to side effects, while underdosing may reduce effectiveness. This new self-regulating system offers a solution—a drug that tunes itself in real time to match what the body needs.